PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS

Twenty nine chronic schizophrenics maintained on trifluperazinc treatment were included in the trial trifluperazinc was discontinued till relapse occured. Standard injectable trifluperazinc was reinstituted for 10 days. This was replaced by weekly dose of 20-40 mg penfluridol orally for a period of...

Descripción completa

Detalles Bibliográficos
Autor principal: Sharma, S. D.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 1988
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008798/
https://www.ncbi.nlm.nih.gov/pubmed/21927345
_version_ 1782194554025279488
author Sharma, S. D.
author_facet Sharma, S. D.
author_sort Sharma, S. D.
collection PubMed
description Twenty nine chronic schizophrenics maintained on trifluperazinc treatment were included in the trial trifluperazinc was discontinued till relapse occured. Standard injectable trifluperazinc was reinstituted for 10 days. This was replaced by weekly dose of 20-40 mg penfluridol orally for a period of d months. Assessment was done monthly and side effects were monitored. At the end of 6 months, 28 patients not only maintained but improved in the psychiatric status. The trial has confirmed that penfluridol is a safe and effective drug which would be suitable for maintenance therapy in schizophrenic patients.
format Text
id pubmed-3008798
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30087982011-09-16 PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS Sharma, S. D. Indian J Psychiatry Original Article Twenty nine chronic schizophrenics maintained on trifluperazinc treatment were included in the trial trifluperazinc was discontinued till relapse occured. Standard injectable trifluperazinc was reinstituted for 10 days. This was replaced by weekly dose of 20-40 mg penfluridol orally for a period of d months. Assessment was done monthly and side effects were monitored. At the end of 6 months, 28 patients not only maintained but improved in the psychiatric status. The trial has confirmed that penfluridol is a safe and effective drug which would be suitable for maintenance therapy in schizophrenic patients. Medknow Publications 1988 /pmc/articles/PMC3008798/ /pubmed/21927345 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sharma, S. D.
PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title_full PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title_fullStr PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title_full_unstemmed PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title_short PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
title_sort penufluridol in the treatment of schizophrenics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008798/
https://www.ncbi.nlm.nih.gov/pubmed/21927345
work_keys_str_mv AT sharmasd penufluridolinthetreatmentofschizophrenics

Ejemplares similares